<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">Naïve-ZIKV-IG and ZIKV-IG were initially diluted to 0.1 mg/mL and then serially diluted 1:3 for 11 dilutions in RPMI 1640 medium supplemented with 1% Hepes and 1% penicillin/streptomycin. Antibody dilutions were incubated at 37 °C with 5% CO
 <sub>2</sub> for 1 hr with either 1 × 10
 <sup>5</sup> FFU of ZIKV strain FSS13025, 2 × 10
 <sup>4</sup> FFU of ZIKV strain MR766, or 1 × 10
 <sup>4</sup> FFU of ZIKV strain PRVABC59. Standard flow cytometry-based neutralization assays using U937-DC-SIGN cells were then performed as described previously
 <sup>
  <xref ref-type="bibr" rid="CR58">58</xref>,
  <xref ref-type="bibr" rid="CR86">86</xref>,
  <xref ref-type="bibr" rid="CR93">93</xref>
 </sup>.
</p>
